x
|
No
fee required
|
o
|
Fee
computed on table below per Exchange Act Rules 14a- 6(i)(1) and
0-11.
|
(1)Title
of each class of securities to which transaction
applies:
|
|
(2)Aggregate
number of securities to which transaction applies:
|
|
(3)Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is
calculated and state how it was determined):
|
|
(4)Proposed
maximum aggregate value of transaction:
|
|
(5)Total
fee paid:
|
|
o
|
Fee
paid previously with preliminary materials.
|
o
|
Check
box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
|
(1)
Amount Previously Paid:
|
|
(2)
Form, Schedule or Registration Statement No.:
|
|
(3)
Filing Party:
|
|
(4)
Date Filed:
|
|
Sincerely,
/s/
Thomas L.
Massie
Thomas
L. Massie
President
and Chief Executive Officer
|
1.
|
To
elect two directors;
|
|
2.
|
To
ratify the appointment of UHY LLP as the Company’s independent registered
public accounting firm for its fiscal year ending September 30, 2009;
and
|
3.
|
To
transact such other business as may properly come before the
Meeting.
|
By Order
of the Board of Directors
/s/ Gary
Cebula
Gary
Cebula
Assistant
Secretary
March
4, 2009
|
1.
|
Consider
and act upon a motion to elect two directors;
|
|
|
2.
|
Consider
and act upon a motion to ratify the appointment of UHY LLP as the
Company’s independent registered public accounting firm for its fiscal
year ending September 30, 2009; and
|
3.
|
Transact
such other business as may properly come before the
Meeting.
|
Name
|
Age
|
Position
with the Company
|
Director
Since
|
Nominees
for Directors for
Terms
Expiring in 2012
|
|||
William
Coldrick*
|
66
|
Director
Chair
of the Nominating and Corporate Governance Committee
Member
of the Compensation Committee and Audit Committee
|
2000
|
Thomas
Massie
|
47
|
Chairman
of the Board of Directors
President
Chief
Executive Officer
|
2000
|
Directors
with Terms
Expiring
in 2011
|
|||
Robert
Hegarty*
|
46
|
Director
Chair
of the Compensation Committee
Member
of the Nominating and Corporate Governance Committee
|
2006
|
John
Cavalier*
|
69
|
Director
Member
of the Audit Committee, the Compensation Committee and the Nominating and
Corporate Governance Committee
|
2007
|
Director
with Term
Expiring
in 2010
|
|||
Kenneth
Galaznik*
|
57
|
Director
Chair
of the Audit Committee
|
2006
|
Name
|
Number
of Shares Owned
|
Percent
of Outstanding Shares
|
||
P.A.W.
Capital Corp
4
Greenwich Office Park, 3rd
Floor
Greenwich,
CT 06831
|
639,900 (1)
|
|
5.84%
|
|
Family
Capital Trust Co., N.A.
33 Broad St.
Boston, MA
02109
|
367,397 (2)
|
3.35%
|
||
Merrill
Lynch & Co., Inc.
4 World Financial
Center
250 Vesey
St.
New York, NY
10080
|
320,000 (2)
|
2.92%
|
||
Thomas
Massie
|
888,334 (3)
|
8.11%
|
||
John
Cavalier
|
93,333
|
*
|
||
William
Coldrick
|
64,667
|
*
|
||
Kenneth
Galaznik
|
—
|
—
|
||
Robert
Hegarty
|
12,000 (4)
|
|
*
|
|
Erez
Katz
|
750,584
|
6.85%
|
||
Steven
Saraceno
|
273,571
|
2.50%
|
||
Timothy
Higgins
|
266,449
|
2.43%
|
||
Russ
Klitchman
|
238,423
|
2.18%
|
||
Anthony
Pietrocola
|
201,144
|
1.84%
|
||
Rob
Seeger
|
185,188 (5)
|
1.69%
|
||
Michael
Matteo
|
143,658
|
1.31%
|
||
William
Matteson
|
126,000
|
1.15%
|
||
Gary
Cebula
|
107,666
|
*
|
||
Brett
Zucker
|
81,323 (6)
|
*
|
||
All
current executive officers, directors and senior management as a
group (15 persons)
|
3,386,705 (7)
|
|
31.34%
|
(1)
|
Based on
the Schedule 13G filed by the holder on January 14,
2009.
|
(2)
|
Based on
publicly available information as of September 30,
2008.
|
(3)
|
Includes
6,667 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days of January
22, 2009). Includes shares issuable upon exercise of a warrant to purchase
10,000 shares of common stock at an exercise price of $.001 per
share.
|
(4)
|
Includes
2,000 shares of common stock beneficially owned by Mr. Hegarty’s
spouse.
|
(5)
|
Includes
shares issuable upon exercise of a warrant to purchase 5,000 shares of
common stock at an exercise price of $0.001 per
share.
|
(6)
|
Includes
1,820 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days
of January 22, 2009).
|
(7)
|
Includes
8,487 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days of January
22, 2009).
|
Name
and Principal Position
|
Year
|
Salary
($)
|
Bonus
($)
|
Option
Awards
($)(2)
|
All
Other Compensation ($)
|
Total
($)(2)
|
Thomas
Massie
Chief
Executive Officer and Director
|
2008
2007
|
225,000
150,000
|
38,750
55,000
|
161,800
—
|
24,242
(1)
24,242
(1)
|
449,792
229,242
|
Gary
Cebula
Chief
Financial Officer
|
2008
2007
|
175,000
141,250
|
36,000
57,500
|
39,600
52,000
|
—
|
250,600
250,750
|
Brett
Zucker
Executive
Vice President and Chief Technology Officer
|
2008
2007
|
175,000
155,000
|
46,300
50,500
|
77,200
—
|
—
|
298,500
205,500
|
(1)
|
Represents
life insurance premiums.
|
||||
(2)
|
Amounts
shown do not reflect compensation actually received by the named executive
officer. The amounts in the Option Awards column reflect the dollar amount
recognized as compensation cost for financial statement reporting purposes
for the fiscal year ended September 30, 2008 and 2007 in accordance with
SFAS 123(R) for all stock options granted in the fiscal years ended
September 30, 2008 and 2007. The calculation in the table above excludes
all assumptions with respect to forfeitures. There can be no assurance
that the amounts set forth in the Option Awards column will ever be
realized. A forfeiture rate was used in the expense calculation in the
financial statements.
|
Option
Awards (4)
|
||||
Name
|
Number
of Securities Underlying Unexercised Options (#)
Exercisable
|
Number
of Securities Underlying Unexercised Options (#)
Unexercisable
|
Option
Exercise Price
($)
|
Option
Expiration Date
|
Thomas
Massie
(1)
|
33,333
6,667
|
—
—
75,000
20,000
|
3.000
0.003
3.690
1.760
|
09/03/2012
09/30/2012
10/26/2017
08/19/2018
|
Gary
Cebula
(2)
|
25,000
100,000
25,000
|
—
—
—
10,000
20,000
|
3.000
3.750
3.750
3.690
1.760
|
06/01/2013
06/01/2015
04/23/2017
10/26/2017
08/19/2018
|
Brett
Zucker
(3)
|
1,820
16,797
8,333
25,000
100,000
|
—
—
—
—
—
30,000
20,000
|
0.357
1.072
3.000
3.000
3.750
3.690
1.760
|
02/27/2012
02/27/2012
02/27/2012
06/01/2013
06/01/2015
10/26/2017
08/19/2018
|
(1)
|
Grants
dated 9/03/2002, 9/30/2002, 10/26/07, and 08/19/08 for 33,333, 6,667,
75,000, and 20,000 shares, respectively. Shares vest in equal
installments upon the anniversary date of the grant over three
years.
|
|||||
(2)
|
Grants
dated 6/01/2003, 06/01/2005, 04/23/2007, 10/26/07, and 08/19/08 for
25,000, 100,000, 25,000, 10,000, and 20,000 shares, respectively. Shares
vest in equal installments upon the anniversary date of the grant over
three years.
|
|||||
(3)
|
Grants
dated 2/27/2002, 6/1/2003, 6/1/2005, 10/26/07, and 08/18/08 for 26,950,
25,000, 100,000, 30,000 and 20,000 respectively. Shares vest in equal
installments upon the anniversary date of the grant over three
years.
|
|||||
(4) |
In
October 2008, the Board of Directors approved a repricing plan (the
“Repricing Plan”) for each holder of stock options of the Company,
including each named executive officer and non-employee
directors. The Repricing Plan is an offer to terminate existing
outstanding stock options in exchange for replacement stock options for
the exact number of shares with a lower exercise price equal to the
current fair market of the Common Stock on the date of the repricing. A
new three year vesting schedule starting on the date of the repricing also
applies to the replacement options.
|
Name
|
Fees
Earned or Paid in
Cash
($)
|
Option
Awards
($)(1)(2)
|
All
Other
Compensation
($)
|
Total
($)
|
William
Coldrick
|
23,000
|
29,200
|
—
|
52,200
|
Kenneth
Galaznik
|
26,000
|
29,200
|
—
|
55,200
|
Robert
Hegarty
|
23,000
|
29,200
|
—
|
52,200
|
John
Cavalier
|
18,000
|
29,200
|
—
|
47,200
|
(1)
|
The
amounts in this column represent stock option grants. All stock
option grants vest in equal installments over three years. This
column represents the dollar amount recognized as compensation cost for
financial statement reporting purposes for the fiscal year ended September
30, 2008 in accordance with SFAS 123(R) for all stock options granted in
the fiscal year ended September 30, 2008. The calculation in the table
above excludes all assumptions with respect to forfeitures. There can be
no assurance that the amounts set forth in the Option Awards column will
ever be realized.
|
(2)
|
Stock
options to purchase 10,000 shares were granted on 10/27/08 and
8/18/08.
|
Name
|
Number
of Shares Underlying Outstanding Stock Options
|
|
William
Coldrick
|
36,667
|
|
Kenneth
Galaznik
|
45,000
|
|
Robert
Hegarty
|
45,000
|
|
John
Cavalier
|
20,000
|
Type
of Service
|
Amount
of Fee for
|
|
Fiscal
2008
|
Fiscal
2007
|
|
Audit
Fees
|
$
224,277
|
$
687,784
|
Audit-Related
Fees
|
58,609
|
—
|
Tax
Fees
|
—
|
3,000
|
Total
|
$
282,886
|
$
690,784
|
A.
|
To
elect the following nominees as
directors.
|
For
|
Withhold
|
||||
1
|
William
Coldrick
|
o
|
o
|
||
2
|
Thomas
Massie
|
o
|
o
|
B.
|
To
ratify the appointment of UHY LLP as the Company’s independent auditors
for the Company’s fiscal year ending September 30,
2009.
|
o
For
|
o
Against
|
o
Abstain
|
C.
|
In
their discretion, on such other matters as may properly come before the
meeting.
|
o
For
|
o
Against
|
o
Abstain
|